We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Pharmaceuticals.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Pharmaceuticals Product List and Ranking from 10 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

Pharmaceuticals Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

  1. 関東化学株式会社 バイオケミカル部 Tokyo//Chemical
  2. Kaminashi inc. Tokyo//Information and Communications
  3. Panorama Data Insights Ltd. Tokyo//Testing, Analysis and Measurement
  4. 4 null/null
  5. 5 null/null
Go to Company Ranking

Pharmaceuticals Product ranking

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

  1. Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals 関東化学株式会社 バイオケミカル部
  2. What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles. Kaminashi inc.
  3. [Market Report] Global Nausea Relief Chewable Market Panorama Data Insights Ltd.
  4. 4 Tohoku University Technology: Nucleic acid molecule that increases insulin-secreting β cells: T14-170
  5. 4 【Industry-Specific Utilization Methods】Pharmaceuticals ワコン

Pharmaceuticals Product List

1～15 item / All 20 items

Displayed results
Technical Information Magazine 201911-03 Pharmaceuticals in the Era of Modalities Diversification

Technical Information Magazine 201911-03 Pharmaceuticals in the Era of Modalities Diversification

The technical information magazine The TRC News provides the latest information on analytical techniques that are useful for research and development, solving production troubles, and quality control.

**Abstract** In recent years, as pharmaceutical modalities such as cell therapies and nucleic acid medicines have rapidly advanced, new methods for quality evaluation that are not present in traditional pharmaceutical quality control are required. Our CMC Analysis Research Department, building on 20 years of experience in the standard testing of small molecules and antibody drugs, has quickly introduced analytical functions required for new pharmaceutical modalities and operates under a GMP framework. This paper presents examples of analytical functions applicable to ADCs, cell therapies, and nucleic acid medicines. **Table of Contents** 1. Introduction 2. Analysis of Aggregates in Human IgG Antibodies by SEC-MALS 3. Analysis of Residual Solvents in Nucleic Acids by GC-MS 4. Cell Analysis by Flow Cytometry 5. DNA Quantification by Quantitative PCR 6. Conclusion

  • Contract Analysis
  • Contract measurement
  • Technical and Reference Books

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Launch of quality evaluation services for the development and application of extracellular vesicle pharmaceuticals.

Launch of quality evaluation services for the development and application of extracellular vesicle pharmaceuticals.

Providing comprehensive analytical support for the social implementation of extracellular vesicles.

Our company (hereinafter referred to as "TRC") has launched a service for pharmaceutical applications of extracellular vesicles as part of our analytical support for the social implementation of extracellular vesicles. Extracellular vesicles are small vesicles (small bag-like structures enclosed by a membrane) secreted by cells that transport biomolecules such as proteins and nucleic acids, playing a crucial role in intercellular communication. In recent years, the development of drugs utilizing extracellular vesicles as drug delivery systems (extracellular vesicle drugs) has been advancing, but there are few companies capable of conducting analyses that meet the stringent standards for pharmaceutical applications, making the establishment of an analytical framework for drug applications urgent. Therefore, TRC has started a quality evaluation service for the development and application of extracellular vesicle drugs, contributing to the social implementation of extracellular vesicles.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles.

What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles.

This will introduce the basic concepts of GMP, the differences between food and pharmaceutical GMP, and the steps to start implementing GMP.

GMP serves as a standard that underpins the quality of products such as food, pharmaceuticals, and cosmetics. Originally, GMP is a concept that ensures the safety of all "manufacturing." Since GMP is constantly evolving, there are aspects that can be difficult to understand or cumbersome. This article will introduce the fundamental concepts of GMP, the differences between GMP and GMP ordinances, the distinctions between food and pharmaceutical GMP, and the steps to start implementing GMP. *For detailed content of the article, please refer to the link below.*

  • HACCP Management System

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals

Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals

Usable from product development to actual manufacturing! 'Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals'

We sell "manufacturing-only pharmaceuticals" that can be used from product development to actual manufacturing. We supply products under strict quality control, including additional conformity testing for international standards. When purchasing this product (manufacturing-only pharmaceuticals), a license and a confirmation document are required in accordance with the Pharmaceutical and Medical Device Act. For more details, please refer to the catalog below.

  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Features of Aptamers

Features of Aptamers

Fits the shape of proteins! Nucleic acid molecules that can inhibit or regulate.

We would like to introduce the features of the "aptamer" that we handle. Single-stranded nucleic acids form various three-dimensional structures according to their sequences. Utilizing this structural capability, these nucleic acid molecules can bind to target proteins and inhibit or regulate their functions. Please feel free to contact us when you need assistance. 【Features】 ■ Creates a three-dimensional structure that fits the shape of the protein for binding, known as "shape capture." *For more details, please refer to the PDF materials or feel free to contact us.

  • Pharmaceutical Intermediates

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Reagents, scientific instruments, pharmaceuticals

Reagents, scientific instruments, pharmaceuticals

Leave it to us for products related to research and development, including bio, genome, nanotechnology, with a core focus on reagent sales.

Our company has been providing products such as reagents, clinical testing agents, industrial chemicals, and scientific instruments to contribute to various users, including academic research institutions, industrial sectors, and the medical field, as a comprehensive reagent dealer. As a support industry for research and development, we will respond to advancements in science and technology and technological innovation by providing the information our customers seek and promoting proposal-based sales. Please feel free to contact us with any requests. 【Business Areas】 ■ Bio ■ Chemical ■ Clinical Testing ■ Quality Control and Analysis *For more details, please download the PDF or feel free to contact us.

  • Other contract services
  • Clinical Development Systems

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Keywords: microRNA, viral defense mechanisms, cell death due to viral infection, siRNA, nucleic acid medicines

mRNA is RNA that contains information for protein synthesis, but there are also many non-coding RNAs in the cell that do not carry messages. We have been elucidating the mechanisms by which immune responses to RNA virus infections are regulated by small non-coding RNAs called microRNAs. Understanding this mechanism may contribute to the development of novel nucleic acid medicines. Additionally, while siRNA also suppresses the expression of mRNA, siRNA has a suppressive effect on a single gene, whereas microRNA acts on entire specific gene groups. Although there are currently no nucleic acid medicines utilizing microRNA, we are hopeful that if the mechanisms of their action in virus-infected cells are clarified, the potential for nucleic acid medicines will expand even further.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Industry-Specific Utilization Methods】Pharmaceuticals

【Industry-Specific Utilization Methods】Pharmaceuticals

We are introducing the three key points of GDP and two transportation methods corresponding to GDP!

In the pharmaceutical industry, it has become necessary to respond to GDP (Good Distribution Practice), which expands to include storage and transportation in the distribution process, as a complement to the conventional GMP (Good Manufacturing Practice) standards for manufacturing and quality control. Emphasis is placed on ensuring quality throughout the distribution process, with particular importance placed on temperature control. It is required that proper temperature management is maintained from the time products leave the manufacturing facility until they reach the patient. Wacon will assist you in complying with GDP using refrigerated boxes. *For more detailed information, please refer to the related links. For further details, you can download the PDF or feel free to contact us.*

  • Food transport materials (cooling, heat retention, etc.)

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Service Example] Major Pharmaceutical Company J

[Service Example] Major Pharmaceutical Company J

We will introduce examples of providing extensive support for the preparation of materials for internal controls and lectures for stakeholders, as well as support for the internal implementation of new business launches!

We would like to introduce a case where comprehensive project management was implemented for Company J, a major pharmaceutical company, while considering the legal regulations surrounding pharmaceutical sales. The company was exploring the launch of a new e-commerce platform in order to broaden its user base and achieve further sales growth. After the service was introduced, the synchronization of member information registered on the existing site with the e-commerce system was addressed, allowing purchasing behavior on the e-commerce platform to be reflected in the existing customer database in real-time. We provided extensive support for necessary e-commerce operations both before and after the release. [Challenges] - The company was exploring the launch of a new e-commerce platform to broaden its user base and achieve further sales growth. - There were several concerns regarding the construction of the e-commerce platform, including the specific regulations of the Pharmaceutical and Medical Device Act (formerly the Pharmaceutical Affairs Law) related to pharmaceutical e-commerce and the integration of member information registered on the existing site. *For more details, please refer to the related links or feel free to contact us.*

  • Internal Control and Operational Management

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

World Market for Genetic Engineering Pharmaceuticals: Monoclonal Antibodies, Recombinant Human Erythropoietin, Recombinant Human Interferon, Recombinant Human Growth ...

This research report (Global Genetic Engineering Drug Market) investigates and analyzes the current status and outlook for the global market of genetic engineering pharmaceuticals over the next five years. It includes information on the overview of the global genetic engineering pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the genetic engineering pharmaceuticals market focus on monoclonal antibodies, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin, while the segments by application cover medical, research, industrial, agricultural, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for genetic engineering pharmaceuticals. The report also includes the market share of major companies in genetic engineering pharmaceuticals, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
The global market for recombinant human erythropoietin (rhEPO)

The global market for recombinant human erythropoietin (rhEPO)

World Market for Recombinant Human Erythropoietin (rhEPO): ESRD, Cancer, HIV, Wound & Neurological Diseases, Hospitals, Retail Pharmacies

This research report (Global Recombinant Human Erythropoietin (rhEPO) Market) investigates and analyzes the current status and outlook for the global market of recombinant human erythropoietin (rhEPO) over the next five years. It includes information on the global recombinant human erythropoietin (rhEPO) market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for recombinant human erythropoietin (rhEPO) by type target ESRD, cancer, HIV, and wound/neuro diseases, while the segments by application focus on hospitals and retail pharmacies. The regional segments calculate the market size of recombinant human erythropoietin (rhEPO) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in recombinant human erythropoietin (rhEPO), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Prescription Drugs

[Research Material] The Global Market for Prescription Drugs

World Market for Prescription Pharmaceuticals: PIA, PAA, CUPM, PDA, SAPM, Consumers under 18, Consumers aged 19-44, Consumers aged 45-64 ...

This research report (Global Compounding Pharmacy Market) investigates and analyzes the current state of the global compounding pharmacy market and its outlook for the next five years. It includes information on the overview of the global compounding pharmacy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the compounding pharmacy market focus on PIA, PAA, CUPM, PDA, and SAPM, while the segments by application target consumers under 18 years old, consumers aged 19-44, consumers aged 45-64, and consumers aged 65 and older. The regional segments calculate the market size of compounding pharmacies by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compounding pharmacy sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Plants & Acupuncture Treatment

[Research Material] Global Market for Plants & Acupuncture Treatment

World Market for Herbal Medicine and Acupuncture: Herbs, Acupuncture, OTC (Over-the-Counter), Prescription

This research report (Global Botanicals & Acupuncture Market) investigates and analyzes the current state of the global market for botanicals and acupuncture, as well as its outlook for the next five years. It includes information on the overview of the global botanicals and acupuncture market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the botanicals and acupuncture market focus on botanicals and acupuncture, while the segments by application target OTC (over-the-counter) and prescription. The regional segments calculate the market size for botanicals and acupuncture by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the botanicals and acupuncture market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.